Healthcare >> Analyst Interviews >> January 22, 2001
C. ANTHONY BUTLER, PhD, is a Pharmaceutical/Biotechnology Industry
Analyst, co-Head of Global Pharmaceuticals and a Managing Director. He
was previously associated with Raymond James & Associates. Prior to that
Dr. Butler was a fellow at the Rockefeller University where he performed
genetic engineering research and authored scientific papers. He received
a BS from Baylor University, an MS from the University of Tennessee,
attended New York University's Stern Graduate School and received a PhD
in Molecular Biology. Profile
Dr. Butler: That's an excellent question. I think there are three
particular reasons for investment in pharmaceutical stocks for 2001.
Point
